Boston Scientific (Natick, Massachusetts) has received FDA 510(k) clearance for a next-generation 3-D cardiac mapping and navigation system designed to improve clarity, efficiency, and physician confidence during catheter ablations and electrophysiology (EP) procedures to diagnose or treat a variety of conditions in which the heart beats abnormally.